Comparative effectiveness of bovine carotid artery xenograft and polytetrafluoroethylene in hemodialysis access revision

Abstract

Background:

When hemodialysis arteriovenous accesses fail, autogenous options are often limited. Non-autogenous conduit choices include bovine carotid artery xenografts (BCAG) and expanded polytetrafluoroethylene (PTFE), yet their comparative effectiveness in hemodialysis access revision remains largely unknown.

Methods:

A cohort study was performed from a prospectively collected institutional database from August 2010 to July 2021. All patients undergoing an arteriovenous access revision with either BCAG or PTFE were followed for up to 3 years from their index access revision. Revision was defined as graft placement to address a specific problem of an existing arteriovenous access while maintaining one or more of the key components of the original access (e.g. inflow, outflow, and cannulation zone). Outcomes were measured starting at the date of the index revision procedure. The primary outcome was loss of secondary patency at 3 years. Secondary outcomes included loss of post-intervention primary patency, rates of recurrent interventions, and 30-day complications. Pooled logistic regression was used to estimate inverse probability weighted marginal structural models for the time-to-event outcomes of interest.

Results:

A total of 159 patients were included in the study, and 58% received access revision with BCAG. Common indications for revision included worn out cannulation zones (32%), thrombosis (18%), outflow augmentation (16%), and inflow augmentation (13%). Estimated risk of secondary patency loss at 3 years was lower in the BCAG group (8.6%, 3.9–15.1) compared to the PTFE group (24.8%, 12.4–38.7). Patients receiving BCAG experienced a 60% decreased relative risk of secondary patency loss at 3 years (risk ratio 0.40, 0.14–0.86). Recurrent interventions occurred at similar rates in the BCAG and PTFE groups, with 1.86 (1.31–2.43) and 1.60 (1.07–2.14) interventions at 1 year, respectively (hazard ratio 1.22, 0.74–1.96).

Conclusions:

Under the conditions of this contemporary cohort study, use of BCAG in upper extremity hemodialysis access revision decreased access abandonment when compared to PTFE.

Keywords

Renal dialysis renal replacement therapy kidney failure chronic polytetrafluoroethylene arteriovenous graft

Get full access to this article

View all access options for this article.

References

Johansen

Chertow

Gilbertson

, et al. US renal data system 2021 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2022; 79: A8–A12.

Pisoni

Zepel

Zhao

, et al. International comparisons of native arteriovenous fistula patency and time to becoming catheter-free: findings from the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2020; 77: 245–254.

Dukkipati

Peck

Dhamija

, et al. Biological grafts for hemodialysis access: historical lessons, state-of-the-art and future directions. Semin Dialysis 2013; 26: 233–239.

Kennealey

Elias

Hertl

, et al. A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access. J Vasc Surg 2010; 53: 1640–1648.

Arhuidese

Reifsnyder

Islam

, et al. Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access. J Vasc Surg 2017; 65: 775–782.

Buggs

Tanious

Camba

, et al. Effective arteriovenous fistula alternative for hemodialysis access. Am J Surg 2018; 216: 1144–1147.

Marcus

Echeverria

Cheung

, et al. Early cannulation of bovine carotid artery graft reduces tunneled dialysis catheter-related complications: a comparison of bovine carotid artery graft versus expanded polytetrafluoroethylene grafts in hemodialysis access. Vasc Endovasc Surg 2019; 53: 104–111.

Elm

E von

Altman

Egger

, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18: 800–804.

Hernán

. Causal analyses of existing databases: no power calculations required. J Clin Epidemiol 2022; 144: 203–205.

10.

Schmidli

Widmer

Basile

, et al. Editor’s choice – vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). European J Vasc Endovascular Surg 2018; 55: 757–818.

11.

Shenoy

Allon

Beathard

, et al. Clinical trial end points for hemodialysis vascular access: background, rationale, and definitions. Clin J Am Soc Nephrol 2018; 13: 490–494.

12.

Lok

Huber

Lee

, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75: S1–S164.

13.

Cole

Hernan

. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008; 168: 656–664.

14.

Robins

Finkelstein

. Correcting for noncompliance and dependent censoring in an aids clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000; 56: 779–788.

15.

Hernán

Hernández-Díaz

Robins

. A structural approach to selection bias. Epidemiology 2004; 15: 615–625.

16.

D’Agostino

Lee

Belanger

, et al. Relation of pooled logistic regression to time dependent cox regression analysis: the Framingham heart study. Stat Med 1990; 9: 1501–1515.

17.

Robins

Hernán

MÁ

Brumback

. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550–560.

18.

Yang

Jepson

Xie

, et al. Statistical methods for recurrent event analysis in cohort studies of CKD. Clin J Am Soc Nephrol 2017; 12: 2066–2073.

19.

Prentice

Williams

Peterson

. On the regression analysis of multivariate failure time data. Biometrika 1981; 68: 373–379.

20.

Young

Stensrud

Tchetgen

EJT

, et al. A causal framework for classical statistical estimands in failure-time settings with competing events. Stat Med 2020; 39: 1199–1236.

21.

Efron

Tibshirani

. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986; 1: 54–75.

22.

R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. https://www.R-project.org/ (2022).

23.

Wickham

Averick

Bryan

, et al. Welcome to the tidyverse. J Open Source Softw 2019; 4: 1686.

24.

Kuhn

Wickham

. Tidymodels: a collection of packages for modeling and machine learning using tidyverse principles, https://www.tidymodels.org (2020).

25.

Therneau

Grambsch

. Modeling survival data: extending the cox model. New York, NY: Springer, 2000.

26.

Naimi

Cole

Kennedy

. An introduction to g methods. Int J Epidemiol 2016; 46: 756–762.

27.

Hernán

MÁ

Brumback

Robins

. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11: 561–570.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB

0.31 MB